Systemic treatment and the H1N1 flu vaccine

LÉVIS, Nov. 5 /CNW Telbec/ - The Alliance Québécoise du Psoriasis (Quebec psoriasis alliance) would like to give its members and other psoriasis sufferers information concerning the massive H1N1 vaccination campaign.

All patients who are receiving systemic treatment (methotrexate, cyclosporine, biotherapy) MUST get the flu vaccine as soon as possible. Those taking acitetrin can follow the regular vaccination schedule. It is recommended that anyone receiving biotherapy receive the vaccination. Systemic treatments affect the immune system, which is why it is important to be vaccinated for your protection.

If patients receiving systemic treatment contract the (A)H1N1 virus, they MUST stop treatment until they recover. Be sure to receive a proper diagnosis from a health care specialist. Please note that the information in this press release does not replace the advice of your qualified health care professional.

SOURCE ALLIANCE QUEBECOISE DU PSORIASIS

For further information: For further information: Paul-François Bourgault, CEO of the Alliance Québécoise du Psoriasis, (418) 838-9779, Cell: (418) 558-1153, paul-francois.bourgault@psoriasisquebec.org

Organization Profile

ALLIANCE QUEBECOISE DU PSORIASIS

More on this organization

PSORIASIS QUEBEC.ORG

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890